2023-05-15 19:23:12 ET
- Horizon Therapeutics plunged 15% in after hours trading on a report that the Federal Trade Commission is preparing to file a lawsuit to block the company's $28 billion sale to Amgen ( NASDAQ: AMGN ).
- The FTC had a closed door meeting on Friday where the transaction was discussed and the commissioner's are expected to vote on the deal this week, according to traders, who cited a Capitol Forum report that was circulating on Monday night.
- Developing story ...
For further details see:
Horizon Therapeutics tumbles on report FTC preparing suit to block Amgen deal